Form D — Pahr Therapeutics, Inc.
0001231919-25-000123 · filed Jul 18, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $14,000,002
- Total sold
- $4,666,668
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pahr Therapeutics, Inc.
- CIK
- 2077159
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116 - Phone
- (781) 424-9384
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Neil Buckley · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Ken Horne · DirectorBoston, MA Find on LinkedIn ↗
-
Amanda Creedon · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Andrew Levin · DirectorBoston, MA Find on LinkedIn ↗
-
Atsushi Usami · DirectorBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗